Announcement on Resolutions of 2024 Annual General Meeting
Filed with SSE · · 15 pages · Chinese
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Obtaining Approval for Marketing of Chemical APIs by Branch
- "Corporate Value and Return Enhancement" Action Plan 2025
- Announcement on the Official Listing of Its Subsidiary Guangzhou Pharmaceutical Co., Ltd. on the National Equities Exchange and Quotations (NEEQ)
- Notice on Convening the 2024 Annual General Meeting
- Resignation of a supervisor and election of a new supervisor
Later from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Resolution of the 26th Meeting of the 9th Board of Directors
- Announcement on Subsidiary Obtaining Drug Supplementary Application Approval
- Announcement on Participation in the Investment and Establishment of Equity Investment Fund and Related Party Transactions
- Full Text of 2025 Semi-annual Report
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical